Scheduled and Breakthrough Opioid Use for Cancer Pain in an Inpatient Setting at a Tertiary Cancer Hospital.

MLA

Rozman de Moraes, Aline, et al. “Scheduled and Breakthrough Opioid Use for Cancer Pain in an Inpatient Setting at a Tertiary Cancer Hospital.” Current Oncology (Toronto, Ont.), vol. 31, no. 3, Mar. 2024, pp. 1335–47. EBSCOhost, https://doi.org/10.3390/curroncol31030101.

APA

Rozman de Moraes, A., Erdogan, E., Azhar, A., Reddy, S. K., Lu, Z., Geller, J. A., Graves, D. M., Kubiak, M. J., Williams, J. L., Wu, J., Bruera, E., & Yennurajalingam, S. (2024). Scheduled and Breakthrough Opioid Use for Cancer Pain in an Inpatient Setting at a Tertiary Cancer Hospital. Current Oncology (Toronto, Ont.), 31(3), 1335–1347. https://doi.org/10.3390/curroncol31030101

Chicago

Rozman de Moraes, Aline, Elif Erdogan, Ahsan Azhar, Suresh K Reddy, Zhanni Lu, Joshua A Geller, David Mill Graves, et al. 2024. “Scheduled and Breakthrough Opioid Use for Cancer Pain in an Inpatient Setting at a Tertiary Cancer Hospital.” Current Oncology (Toronto, Ont.) 31 (3): 1335–47. doi:10.3390/curroncol31030101.